GENB compared with FHTX: revenue, margins and what each company keeps, and the suppliers and customers both name

GENBGenerate Biomedicines, Inc.

Mkt capRevenueRevenue

FHTXFoghorn Therapeutics Inc.

Mkt capRevenueRevenue

Compare

GENBGenerate Biomedicines, Inc.

FHTXFoghorn Therapeutics Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GENB 4

AMGNAmgencustomer

NVSNovartis Pharmacustomer

—The University of Texas MD Anderson Cancer Centerunlistedsupplier

—Roswell Park Comprehensive Cancer Centerunlistedsupplier

Shared 0

No shared counterparties.

Only FHTX 2

LLYEli Lillycustomer

MRKMerck Sharp & Dohmecustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

GENBGenerate Biomedicines, Inc.

13.20▼−8.72%· post 13.40

Mkt cap$1.9BRevenue$6MQ2 FY26Revenue—

FHTXFoghorn Therapeutics Inc.

2.13▲+2.20%· post 2.13

ClosedNov 2 '26

Mkt cap$123.5MRevenue$16MQ2 FY26Revenue$31MFY25

Compare

ClosedNov 2 '26

GENBGenerate Biomedicines, Inc.

FHTXFoghorn Therapeutics Inc.

13.20▼−8.72%post 13.40

Price

2.13▲+2.20%post 2.13

$1.9B

Mkt cap

$123.5M

Q2 FY26$6M

Revenue

$16MQ2 FY26

—

Revenue

$31MFY25

GENB13.20▼−8.72%vsFHTX2.13▲+2.20%ClosedNov 2 '26